Home » Newsletters » The Carlat Psychiatry Report

The Carlat Psychiatry Report

Practical Psychotherapy (November/December) | 2020

View Archived Issues

CME Post-Test - Practical Psychotherapy, TCPR, November/December 2020

November 12, 2020

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits. Read More

Is Ramelteon an Effective Hypnotic?

November 12, 2020

Randall Moore, MD, JD. and Chris Aiken, MD.

Ramelteon (Rozerem) is one of the safer sleep medications, but how well does its efficacy stack up against other hypnotics? The answer surprised us. Read More

Side Effects of Psychotherapy

November 12, 2020

Michael Linden, MD, PhD

Psychotherapy can work as well as medication, but can it also have side effects? Michael Linden believes it can. He launched some of the key studies that brought light to this under-appreciated phenomenon, and in this interview he shows us how to recognize and avoid them. Read More

Brief Therapy During the Medication Visit

November 12, 2020

Donna Sudak, MD

Every minute counts in the 90833 “brief therapy with medication” visit, and Donna Sudak shows us how to customize CBT with pharmacotherapy for depression, bipolar, anxiety disorders, and schizophrenia. Read More

How to Select an SSRI

November 12, 2020

Chris Aiken, MD.

After digging through 3 decades of research, we can tell you this: There is no such thing as “the best” SSRI. But there are some important differences between them, and this article will show you how to find the right one for your patient. Read More

Metformin ER Recalled Due to Cancer Risk

November 12, 2020

Adam Strassberg, MD.

Generic metformin is being recalled by the batches, but is any of it still safe to prescribe? Read More

Chemical Exposures

November 12, 2020

Chris Aiken, MD

Two recent studies add to the mounting evidence that environmental toxins deserve a place in the bio-psycho-social-spiritual model. The first study correlated ADHD symptoms with exposure to endocrine-disrupting chemicals found in plastics, pesticides, and processed food. The second study was a meta-analysis of ultra-processed food consumption from 23 cross-sectional and prospective cohort studies. Read More

Beta Blockers and Depression: The Controversy Revisited

November 12, 2020

Sean Ransom, PhD, MP.

Antihypertensives are among the world’s most widely prescribed drugs, but many of them impact pathways associated with depression. Beta blockers have long been believed to cause depression, but most of these studies were carried out decades ago and their findings have been inconsistent. Read More